US FDA Frustrates Valneva With Chikungunya Vaccine Decision Delay
PDUFA Date For VLA1553 Pushed Out To November
Valneva is sticking by its forecast of getting US approval, and getting hold of a lucrative priority review voucher before the end of the year, despite the Food and Drug Administration needing more time to evaluate the French vaccine specialist’s single shot for chikungunya.
